These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 19201994)
1. Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy. Shen JB; Shutt R; Agosto M; Pappano A; Liang BT Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H1089-95. PubMed ID: 19201994 [TBL] [Abstract][Full Text] [Related]
2. P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure. Shen JB; Cronin C; Sonin D; Joshi BV; Gongora Nieto M; Harrison D; Jacobson KA; Liang BT Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1077-84. PubMed ID: 17040972 [TBL] [Abstract][Full Text] [Related]
3. Modulation of SR Ca2+ release by the triadin-to-calsequestrin ratio in ventricular myocytes. Kučerová D; Baba HA; Bokník P; Fabritz L; Heinick A; Mát'uš M; Müller FU; Neumann J; Schmitz W; Kirchhefer U Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2008-17. PubMed ID: 22427521 [TBL] [Abstract][Full Text] [Related]
4. A beneficial role of cardiac P2X4 receptors in heart failure: rescue of the calsequestrin overexpression model of cardiomyopathy. Yang A; Sonin D; Jones L; Barry WH; Liang BT Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1096-103. PubMed ID: 15130891 [TBL] [Abstract][Full Text] [Related]
5. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha. Janczewski AM; Kadokami T; Lemster B; Frye CS; McTiernan CF; Feldman AM Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H960-9. PubMed ID: 12578819 [TBL] [Abstract][Full Text] [Related]
6. Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin. Knollmann BC; Knollmann-Ritschel BE; Weissman NJ; Jones LR; Morad M J Physiol; 2000 Jun; 525 Pt 2(Pt 2):483-98. PubMed ID: 10835049 [TBL] [Abstract][Full Text] [Related]
7. Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: implication for a role of cardiac purinergic P2X receptors. Zhou SY; Mamdani M; Qanud K; Shen JB; Pappano AJ; Kumar TS; Jacobson KA; Hintze T; Recchia FA; Liang BT J Pharmacol Exp Ther; 2010 Jun; 333(3):920-8. PubMed ID: 20200116 [TBL] [Abstract][Full Text] [Related]
8. Characterization and mechanism of P2X receptor-mediated increase in cardiac myocyte contractility. Shen JB; Shutt R; Pappano A; Liang BT Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H3056-62. PubMed ID: 17873021 [TBL] [Abstract][Full Text] [Related]
9. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849 [TBL] [Abstract][Full Text] [Related]
10. Extracellular ATP-stimulated current in wild-type and P2X4 receptor transgenic mouse ventricular myocytes: implications for a cardiac physiologic role of P2X4 receptors. Shen JB; Pappano AJ; Liang BT FASEB J; 2006 Feb; 20(2):277-84. PubMed ID: 16449800 [TBL] [Abstract][Full Text] [Related]
11. Role of P2X purinergic receptors in the rescue of ischemic heart failure. Sonin D; Zhou SY; Cronin C; Sonina T; Wu J; Jacobson KA; Pappano A; Liang BT Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1191-H1197. PubMed ID: 18641271 [TBL] [Abstract][Full Text] [Related]
12. Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy. Davis J; Yasuda S; Palpant NJ; Martindale J; Stevenson T; Converso K; Metzger JM J Mol Cell Cardiol; 2012 Sep; 53(3):446-57. PubMed ID: 22683325 [TBL] [Abstract][Full Text] [Related]
13. Functional properties of transgenic mouse hearts overexpressing both calsequestrin and the Na(+)-Ca(2+) exchanger. Linck B; Bokník P; Huke S; Kirchhefer U; Knapp J; Lüss H; Müller FU; Neumann J; Tanriseven Z; Vahlensieck U; Baba HA; Jones LR; Philipson KD; Schmitz W J Pharmacol Exp Ther; 2000 Aug; 294(2):648-57. PubMed ID: 10900244 [TBL] [Abstract][Full Text] [Related]
14. Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation and pulsus alternans in vivo. Schmidt AG; Kadambi VJ; Ball N; Sato Y; Walsh RA; Kranias EG; Hoit BD J Mol Cell Cardiol; 2000 Sep; 32(9):1735-44. PubMed ID: 10966834 [TBL] [Abstract][Full Text] [Related]
15. A novel contractile phenotype with cardiac transgenic expression of the human P2X4 receptor. Hu B; Mei QB; Yao XJ; Smith E; Barry WH; Liang BT FASEB J; 2001 Dec; 15(14):2739-41. PubMed ID: 11606481 [TBL] [Abstract][Full Text] [Related]
16. Cardiac-Directed Expression of Adenylyl Cyclase Catalytic Domain ( Tan Z; Giamouridis D; Lai NC; Kim YC; Guo T; Xia B; Gao MH; Hammond HK Hum Gene Ther; 2019 Jun; 30(6):682-692. PubMed ID: 30638074 [TBL] [Abstract][Full Text] [Related]
17. Novel protective role of endogenous cardiac myocyte P2X4 receptors in heart failure. Yang T; Shen JB; Yang R; Redden J; Dodge-Kafka K; Grady J; Jacobson KA; Liang BT Circ Heart Fail; 2014 May; 7(3):510-8. PubMed ID: 24622244 [TBL] [Abstract][Full Text] [Related]